BIOCRYST PHARMACEUTICA
7.6700
07-十一月-24 15:59:59
15 分钟延时
股票
-0.0600
-0.78%
今日范围
7.5050 - 7.8800
ISIN
N/A
来源
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
06 11月 2024 07:00:53 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 11月 2024 07:00:47 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
04 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
24 10月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2024 Financial Results on November 4
21 10月 2024 07:00:23 条件 Nasdaq GlobeNewswire
-
14 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 10月 2024 07:00:53 条件 Nasdaq GlobeNewswire
-
02 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium
06 9月 2024 02:00:11 条件 Nasdaq GlobeNewswire
-
BioCryst Appoints Dr. Donald Fong Chief Medical Officer
05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 9月 2024 07:00:46 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
03 9月 2024 10:02:32 条件 NetDania Notify
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
29 8月 2024 10:17:26 条件 NetDania Notify
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
28 8月 2024 09:45:07 条件 NetDania Notify
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
26 8月 2024 09:45:03 条件 NetDania Notify
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
23 8月 2024 10:45:41 条件 NetDania Notify
-
BioCryst to Present at Upcoming Investor Conferences
22 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
09 8月 2024 09:45:50 条件 NetDania Notify
- <<
- <
- 1
- >